Trial Profile
A single center, cohort study to evaluate reconstitution of the peripheral B lymphocyte compartment in patients with Acna-associated vasculitides treated with rituximab for relapsing or refractory disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jul 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Granulomatosis with polyangiitis; Microscopic polyangiitis
- Focus Therapeutic Use
- 30 Jul 2015 New trial record